Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 8265150, 11 pages
https://doi.org/10.1155/2018/8265150
Research Article

Small Peptides Compound Isolated from Agkistrodon with Antiarthritic Effect in Collagen-Induced Arthritis Rats

1Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China
2Zhejiang University of Technology, Hangzhou, Zhejiang 310014, China

Correspondence should be addressed to Li Xu; moc.361@bhhilux and Yong-Sheng Fan; moc.621@mctjzelppa

Received 30 November 2017; Revised 28 February 2018; Accepted 22 March 2018; Published 29 April 2018

Academic Editor: Antonella Fioravanti

Copyright © 2018 Lijun Mei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Stenman, M. Ainola, L. Valmu et al., “Trypsin-2 degrades human type II collagen and is expressed and activated in mesenchymally transformed rheumatoid arthritis synovitis tissue,” The American Journal of Pathology, vol. 167, no. 4, pp. 1119–1124, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Mateen, A. Zafar, S. Moin, A. Q. Khan, and S. Zubair, “Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis,” Clinica Chimica Acta, vol. 455, pp. 161–171, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Siebert, A. Tsoukas, J. Robertson, and I. McInnes, “Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases,” Pharmacological Reviews, vol. 67, no. 2, pp. 280–309, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. B. D. Furman, D. S. Mangiapani, E. Zeitler et al., “Targeting pro-inflammatory cytokines following joint injury: acute intra-articular inhibition of interleukin-1 following knee injury prevents post-traumatic arthritis,” Arthritis Research & Therapy, vol. 16, no. 3, article R134, 2014. View at Publisher · View at Google Scholar
  5. D. L. Scott, F. Wolfe, and T. W. J. Huizinga, “Rheumatoid arthritis,” The Lancet, vol. 376, no. 9746, pp. 1094–1108, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Kong, Y. Zhang, C. Liu et al., “Anti-angiogenic effect of triptolide in rheumatoid arthritis by targeting angiogenic cascade,” PLoS ONE, vol. 8, no. 10, Article ID e77513, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J. A. Singh, K. G. Saag, S. L. Bridges Jr. et al., “American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis,” Arthritis Rheumatol, vol. 68, no. 1, pp. 1–26, 2015. View at Google Scholar
  8. J. W. J. Bijlsma, P. M. J. Welsing, T. G. Woodworth et al., “Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial,” The Lancet, vol. 388, no. 10042, pp. 343–355, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. D. D. Obiri, N. Osafo, P. G. Ayande, and A. O. Antwi, “Xylopia aethiopica (Annonaceae) fruit extract suppresses Freunds adjuvant-induced arthritis in Sprague-Dawley rats,” Journal of Ethnopharmacology, vol. 152, no. 3, pp. 522–531, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Zhang, J. Li, Y. Han, X. W. Yu, and L. Qin, “Traditional Chinese medicine in the treatment of rheumatoid arthritis: a general review,” Rheumatology International, vol. 30, no. 6, pp. 713–718, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. D. J. Newman and G. M. Cragg, “Natural products as sources of new drugs over the 30 years from 1981 to 2010,” Journal of Natural Products, vol. 75, no. 3, pp. 311–335, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Dardevet, D. Rani, T. A. El Aziz et al., “Chlorotoxin: A helpful natural scorpion peptide to diagnose glioma and fight tumor invasion,” Toxins, vol. 7, no. 4, pp. 1079–1101, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. Y.-H. Yang, R. Rajaiah, E. Ruoslahti, and K. D. Moudgil, “Peptides targeting inflamed synovial vasculature attenuate autoimmune arthritis,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 108, no. 31, pp. 12857–12862, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. S. Wong, A. Tso, Ali. M. et al., “Novel T-cell inhibiting peptides delay the onset of Type 1 diabetes in non-obese diabetic mice,” Diabetes and Metabolism, vol. 40, no. 3, pp. 229–234, 2014. View at Google Scholar
  15. A. Gomes, S. Ghosh, S. Ghosh et al., “Anti-osteoarthritic activity of Bungarus fasciatus venom fraction BF-F47 involving molecular markers in the rats,” Toxicon, vol. 118, pp. 43–46, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Gomes, P. Datta, T. Das, A. K. Biswas, and A. Gomes, “Anti arthritic and anti inflammatory activity of a cytotoxic protein NN-32 from Indian spectacle cobra (Naja naja) venom in male albino rats,” Toxicon, vol. 90, pp. 106–110, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. Q. Zhu, J. Huang, S.-Z. Wang, Z.-H. Qin, and F. Lin, “Cobrotoxin extracted from Naja atra venom relieves arthritis symptoms through anti-inflammation and immunosuppression effects in rat arthritis model,” Journal of Ethnopharmacology, vol. 194, pp. 1087–1095, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. K. L. Wong, R. N. S. Wong, L. Zhang et al., “Bioactive proteins and peptides isolated from Chinese medicines with pharmaceutical potential,” Chinese Medicine, vol. 9, article 19, 2014. View at Publisher · View at Google Scholar
  19. S. F. Darwish, W. M. El-Bakly, H. M. Arafa, and E. El-Demerdash, “Targeting TNF-α and NF-κB activation by bee venom: Role in suppressing adjuvant induced arthritis and methotrexate hepatotoxicity in rats,” PLoS ONE, vol. 8, no. 11, Article ID e79284, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Bao, Z.-J. Xie, L.-M. Chen, J. Sun, and Y.-S. Fan, “Effects of agkistrodon in different dosage forms on collagen-induced arthritis in rats,” Chinese Journal of Integrative Medicine, vol. 22, no. 12, pp. 902–909, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Tao, H. Schulze-Koops, L. Ma, J. Cai, Y. Mao, and P. E. Lipsky, “Effects of Tripterygium wilfordii Hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production,” Arthritis & Rheumatology, vol. 41, no. 1, pp. 130–138, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Maekawa, N. Yoshikawa, J. Du et al., “The molecular mechanism of inhibition of interleukin-1β-induced cyclooxygenase-2 expression in human synovial cells by Tripterygium wilfordii Hook F extract,” Inflammation Research, vol. 48, no. 11, pp. 575–581, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Zhang, W. Xu, H. Li et al., “Therapeutic effects of total alkaloids of tripterygium wilfordii Hook f. on collagen-induced arthritis in rats,” Journal of Ethnopharmacology, vol. 145, no. 3, pp. 699–705, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. X.-J. Li, Z.-Z. Jiang, and L.-Y. Zhang, “Triptolide: progress on research in pharmacodynamics and toxicology,” Journal of Ethnopharmacology, vol. 155, no. 1, pp. 67–79, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Bo, H. Yonghong, Z. Mingmin et al., “Effect of glycoside of tripterygium wilfordii hook.f on expression of receptor activator of nuclear factor-κb ligand and osteoprotegerin in joints of rat adjuvant induced arthritis,” Herald of Medicine, vol. 5, no. 25, pp. 395–397, 2006. View at Google Scholar
  26. N. Liu, M. Yang, W. Luo et al., “Inhibitory effects of methotrexate and tripterygium glycosides on chemokine CCL5 production in synoviocytes from patients with rheumatoid arthritis,” Journal of the Fourth Military Medical University, vol. 12, no. 27, pp. 1113–1115, 2006. View at Google Scholar
  27. J. Zhao, T. Liu, F. Xu, S. You, C. Li, and Z. Gu, “Anti-arthritic effects of total flavonoids from Juniperus sabina on complete freund's adjuvant induced arthritis in rats,” Pharmacognosy Magazine, vol. 12, no. 47, pp. 178–183, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Ma and R. M. Pope, “The role of macrophages in rheumatoid arthritis,” Current Pharmaceutical Design, vol. 11, no. 5, pp. 569–580, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. I. B. McInnes, C. D. Buckley, and J. D. Isaacs, “Cytokines in rheumatoid arthritis-shaping the immunological landscape,” Nature Reviews Rheumatology, vol. 12, no. 1, pp. 63–68, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. M. C. Genovese, M. Greenwald, C. Cho et al., “A phase II randomized study of subcutaneous ixekizumab, an anti-interleukin-17 monoclonal antibody, in rheumatoid arthritis patients who were naive to biologic agents or had an inadequate response to tumor necrosis factor inhibitors,” Arthritis & Rheumatology, vol. 66, no. 7, pp. 1693–1704, 2014. View at Publisher · View at Google Scholar
  31. J. Alam, I. Jantan, and S. N. A. Bukhari, “Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy,” Biomedicine & Pharmacotherapy, vol. 92, pp. 615–633, 2017. View at Publisher · View at Google Scholar · View at Scopus
  32. Q. Cai, J.-M. Meng, and X.-H. Han, “Clinical study on effect of Agkistrodon antithrombogenase in auxiliary treatment of rheumatoid arthritis,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 22, no. 3, pp. 166–168, 2002. View at Google Scholar · View at Scopus
  33. F. Y. Yang, T. M. Fu, L. W. Guo et al., “Degradation of earthworm extracts prepared by wet superfine grinding in simulated gastrointestinal environment,” Yao Xue Xue Bao, vol. 47, no. 1, pp. 110–115, 2012. View at Google Scholar
  34. R. A. Benson, J. M. Brewer, and A. M. Platt, “Mechanisms of autoimmunity in human diseases: a critical review of current dogma,” Current Opinion in Rheumatology, vol. 26, no. 2, pp. 197–203, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. S.-C. Law, H. Benham, H. H. Reid, J. Rossjohn, and R. Thomas, “Identification of self-antigen-specific T cells reflecting loss of tolerance in autoimmune disease underpins preventative immunotherapeutic strategies in rheumatoid arthritis,” Rheumatic Disease Clinics of North America, vol. 40, no. 4, pp. 735–752, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. M. I. Koenders and W. B. van den Berg, “Novel therapeutic targets in rheumatoid arthritis,” Trends in Pharmacological Sciences, vol. 36, no. 4, pp. 189–195, 2015. View at Publisher · View at Google Scholar
  37. M. Miyara, Y. Ito, and S. Sakaguchi, “TREG-cell therapies for autoimmune rheumatic diseases,” Nature Reviews Rheumatology, vol. 10, no. 9, pp. 543–551, 2014. View at Publisher · View at Google Scholar